Piotr L. Pierog
VP Non-clinical Development @Be Biopharma
Signup · Get unlimited contacts
WORK HISTORY
VP Non-clinical Development @Be Biopharma
Cambridge, MA, US
Established translational medicine readouts for Phase 1 BeCoMe-9 study evaluating CRISPR/Cas9-engineered plasma B cells in adults with moderate-to-severe Hemophilia B- Pioneered development and pIND submission for CRISPR/Cas9-engineered plasma B cell platform targeting enzyme replacement delivery in a rare disease indication- Led computational and data-driven strategies to drive forward and reverse translation across 12+ active non-clinical and clinical programs- Accelerated key non-clinical program milestones through restructured team operations and streamlined data analysis workflows, delivering on timelines with fewer resources
EDUCATION
Rutgers University
Doctor of Philosophy (Ph.D.), Immunology Laboratory Medicine Clinical Pathology and Biomedical Sciences
Montclair State University
BS, Biochemistry
SKILLS
ABOUT PIOTR L. PIEROG
I turn complex biology into clinical clarity for oncology programs:* Experienced in biomarker strategies from IND through BLA* Biomarkers, companion diagnostics, and PK/PD* Built and led teams of 20+ across pharma, biotech, and consulting* Contributed to Kymriah, the first approved CAR-T therapyMy next chapter is a Translational Medicine leadership role where I can apply my experience to maximize the success of clinical stage programs.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.